Effect of Delays in Concordant Antibiotic Treatment on Mortality in Patients With Hospital-Acquired Acinetobacter Species Bacteremia: Emulating a Target Randomized Trial With a 13-Year Retrospective Cohort
Authors:
- Cherry LimCLCherry Lim
- Yin MoYMYin Mo
- Prapit TeparrukkulPTPrapit Teparrukkul
- Maliwan HongsuwanMHMaliwan Hongsuwan
- Nicholas P J DayNDNicholas P J Day
- Direk LimmathurotsakulDLDirek Limmathurotsakul
- Ben S CooperBCBen S Cooper
Open Access
- 27 May 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 190 (11) , 2395-2404
Abstract
Delays in treating bacteremias with antibiotics to which the causative organism is susceptible are expected to adversely affect patient outcomes. Quantifying the impact of such delays to concordant treatment is important for decision-making about interventions to reduce the delays and for quantifying the burden of disease due to antimicrobial resistance. There are, however, potentially important biases to be addressed, including immortal time bias. We aimed to estimate the impact of delays in appropriate antibiotic treatment of patients with Acinetobacter species hospital-acquired bacteremia in Thailand on 30-day mortality by emulating a target trial using retrospective cohort data from Sunpasitthiprasong Hospital in 2003–2015. For each day, we defined treatment as concordant if the isolated organism was susceptible to at least 1 antibiotic given. Among 1,203 patients with Acinetobacter species hospital-acquired bacteremia, 682 had 1 or more days of delays to concordant treatment. Surprisingly, crude 30-day mortality was lower in patients with delays of ≥3 days compared with those who had 1–2 days of delays. Accounting for confounders and immortal time bias resolved this paradox. Emulating a target trial, we found that these delays were associated with an absolute increase in expected 30-day mortality of 6.6% (95% confidence interval: 0.2, 13.0), from 33.8% to 40.4%.Keywords
All Related Versions
This publication has 35 references indexed in Scilit:
- Evaluation of the effect of appropriate antimicrobial therapy on mortality associated with Acinetobacter nosocomialis bacteraemiaClinical Microbiology and Infection, 2013
- The influence of carbapenem resistance on mortality in solid organ transplant recipients with Acinetobacter baumanniiinfectionBMC Infectious Diseases, 2012
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology and Infection, 2012
- Risk Factors for Mortality in Patients with Carbapenem-Resistant Acinetobacter baumannii Bacteremia: Impact of Appropriate Antimicrobial TherapyJournal of Korean Medical Science, 2012
- Risk factors and outcomes of imipenem–resistant Acinetobacter bloodstream infection in North–eastern MalaysiaAsian Pacific Journal of Tropical Biomedicine, 2011
- Impact of early appropriate antimicrobial therapy on survival in Acinetobacter baumannii bloodstream infectionsInternational Journal of Antimicrobial Agents, 2009
- Acinetobacter InfectionNew England Journal of Medicine, 2008
- Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*Critical Care Medicine, 2006
- New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortalityJournal of Clinical Epidemiology, 2004
- Antimicrobial Use and Antimicrobial Resistance: A Population PerspectiveEmerging Infectious Diseases, 2002